Read our latest publications
This strategic plan outlines the major objectives of the NHMRC over the next three years, the major health issues that may emerge in the coming years and the steps needed to address them.
Based on a comprehensive review of the evidence and the translation of this evidence into the Information Paper Water fluoridation: dental and other human health outcomes, this also takes into consideration what the situation is here in Australia compared to elsewhere.
The 30th biannual report.
The NHMRC Corporate Plan 2017–2018 covers the period 2017–18 to 2020–21. It includes NHMRC’s strategic directions, which prior to 2015–16 were set out in the strategic plan.
This Information Paper explores the potential link between water fluoridation and human health based. The 2016 NHMRC Evidence Evaluation shows that water fluoridation helps to reduce tooth decay in children and adults. There is no reliable evidence that water fluoridation at current Australian levels causes health problems.
Promoting social and emotional development and wellbeing of infants in pregnancy and the first year of life
This report Promoting social and emotional development and wellbeing of infants in pregnancy and the first year of life: a NHMRC report on the evidence summarises findings of the evaluation of evidence on the effectiveness of interventions delivered in pregnancy or the first postpartum year.
NHMRC refuses to tolerate fraud and has a commitment to high ethical, moral and legal standards. A key focus of this framework is to raise awareness of fraud among NHMRC staff and other people who deal with NHMRC, to assist in the prevention, detection and reporting of suspected fraud.
The Ethical guidelines on the use of assisted reproductive technology in clinical practice and research (ART guidelines) are used by professional organisations to set standards for the practice of ART.
The 29th biannual report.
This document clarifies the responsibilities of those involved in clinical trials to monitor and report adverse events and other safety issues. Supplementary guidance on other clinical trial safety monitoring and reporting issues is also available*.
This document provides principles and best practice guidance for the care and use of non-human primates for scientific purposes. The document is intended for use by those involved in the care and use of non-human primates for scientific purposes, including institutional animal ethics committees, investigators and animal carers.
The Statement on consumer and community involvement in health and medical research (The Statement), co-authored by the National Health and Medical Research Council (NHMRC) and the Consumers Health Forum of Australia (CHF), aims to guide research institutions, researchers, consumers and community members in the active involvement of consumers and community members in all aspects of health and medical research.
The NHMRC Corporate Plan 2016–2017 covers the period 2016–17 to 2019–20. It includes NHMRC’s strategic directions, which prior to 2015–16 were set out in the strategic plan.
The 28th biannual report.
The NHMRC Complaints Policy sets out NHMRC’s formal procedures for responding to complaints about its activities, policies or decision-making.
Ten of the Best NHMRC research projects 2015 describes ten Australian health and medical research projects chosen from among the thousands of NHMRC funded medical research projects underway in Australia today.
The Ethical guidelines for organ transplantation from deceased donors were developed by NHMRC following a joint request from the Organ and Tissue Authority and the Transplantation Society of Australia and New Zealand.
This book contains key statistics on the outcomes of the 2014 application rounds for NHMRC’s research funding, as well as historical information relating to research funding and activity over the last ten years.
The 27th biannual report.
A guide to the legislative and governance structure to refer to when accessing datasets from publicly funded research. This page also contains a single page summary to the guide and a consumer guide.
The 26th biannual report.
The Guidelines approved under Section 95A of the Privacy Act 1988 are issued for the purposes of Australian Privacy Principles (APPs) and sections 16B(2) and 16B(3) of the Privacy Act.
These guidelines provide a framework in which medical research involving personal information obtained by Commonwealth agencies should be conducted, to ensure the information is protected.
This manual demonstrates the need for clinical ethics capacity in Australian health care organisations and provides guidance for institutions wishing to establish or strengthen an existing clinical ethics service.
Ten of the Best research projects 2014 describes ten Australian health and medical research projects chosen from among the thousands of NHMRC funded medical research projects underway in Australia today.
In 2011 NHMRC reviewed studies relating to the effectiveness of naltrexone implants for the treatment of opioid dependence, determining the implants remain an experimental product, only to be used in a research setting. NHMRC believes further research is required before a statement on safety can be confidently made.
This Statement and Information Paper were designed to inform the community and policy makers of the effects of lead on the human body. Evidence has shown an association with reduced academic achievement, behavioural problems, increased blood pressure and delayed sexual maturation.
This expert review is the summary of key issues from the report Evidence on the Effects of Lead on Human Health.
NHMRC’s Research Translation Faculty was established to suggest action that could be taken in the 2012-15 triennium to address significant evidence practice and policy gaps for Major Health Issues identified in its 2013-15 Strategic Plan. Twelve Cases for Action were submitted to NHMRC in 2015.
This Administrative report: Information Paper: Evidence on the effects of lead on human health refers to the development of the Information paper and Statement as well as background documents relating to the assessment of the evidence on the health effects of lead.
This document: Public consultation — summary of key issues: Draft information paper: Evidence on the effects of lead on human health outlines the key issues raised via public consultation and summaries of the Lead Working Committee’s responses.
This document provides a brief snapshot of the key messages from the NHMRC Corporate Plan 2015-2016.
The Principles for the translation of ‘omics’- based tests from discovery to health care are designed to assist researchers and clinicians in translating omics-based discoveries into properly validated tests that are clinically useful*.
The NHMRC and ARC Statement on Open Researcher and Contributor ID explains NHMRC's position on the ORCID researcher identifier.
NHMRC has been investigating concerns about the impact of wind farms on human health since 2009, following concerns raised by the public.
This administrative report refers to the development of a related information paper, NHMRC Statement and evidence-based background documents.
Following an earlier review of evidence linking wind farms to human health, NHMRC sought to update and review available information. The documents here focus on the methods used to conduct a systematic literature review focusing on noise, shadow flicker and electromagnetic radiation.
Some members of the community have raised concerns about the impact on their health while living near a wind farm.
This information paper summarises the available evidence on the subject along with key issues raised by the public and the expert community.
Examining whether wind farm emissions may affect human health is complex, due to the nature of the emissions and individual perceptions are highly variable. After careful consideration and deliberation of the body of evidence, National Health and Medical Research Council (NHMRC) concludes there is currently no consistent evidence that wind farms cause adverse health effects in humans.
Many Australians report they use complementary medicine, but don't tell their clinicians which may impede treatment.
This resource aims to promote discussions between clinicians and patients about complementary medicine and better equip patients to make informed decisions about their health care.
This document is a five-year analysis of the scientific publication output and citation impact of research funded by NHMRC and of Australian health and medical research generally.
The aim of the report is to measure the impact of NHMRC funding schemes in terms of published journal output.
This Strategic Plan outlines five objectives of NHMRC over a three year period. These include raising the standard of public health in Australia and developing consistent standards, fostering relevant research and training and more.
The Plan also outlines 10 major health issues NHMRC focused on over the same three year period.
This Facts Book contains statistics on the outcomes of the 2013 application rounds for NHMRC’s research funding, as well as historical information over the last ten years. NHMRC is committed to transparency regarding the outcomes of its granting system. More detailed statistics and funding data can be found on the NHMRC website under Data on research.
This guide supports the implementation of the Australian code for the care and use of animals for scientific purposes 8th edition (2013) by providing advise about the specific and unique needs of Australian native mammals can be met when these animals are used for scientific purposes.
It provides information for investigators, institutions, animal ethics committees and all those involved in the care and use of Australian native mammals for scientific purposes.
Since 2010 NHMRC has released annual reports on the characteristics of Australian clinical practice guidelines which provide information about who funds and develops clinical practice guidelines, and describe trends in important quality indicators such as the use of evidence and the disclosure of competing interests.
Genetic tests are easily purchased by consumers, often over the internet and usually without the involvement of a medical professional. These tests can be used in diagnosing medical conditions or pre-dispositions.
The statement highlights issues for medical professionals and consumers regarding the use of health-related genetic testing.
The number of direct to consumer DNA tests consumers can buy over the internet, without the involvement of a doctor, has been rising.
This resource is to inform consumers about test accuracy, privacy legislation and what it may mean for personal insurances and blood relations.
This information has been developed for health practitioners to support discussion with men and their families about prostate-specific antigen testing for prostate cancer. It covers benefits, possible risks, current research and frequently asked questions.
The Privacy Legislation Amendment Act 2006 (Cth) made changes to the Privacy Act 1988(Cth) (the Privacy Act) to allow health practitioners to disclose patient’s genetic information, whether or not they give consent, in circumstances where there is reasonable belief that doing so is necessary to lessen or prevent a serious threat to the life, health or safety of their genetics relative(s). The amendments do not oblige disclosure of information but provide the framework for this to occur under the appropriate circumstances.
Ten of the Best research projects 2013 showcases ten Australian health and medical research projects chosen from among the thousands of NHMRC funded medical research projects underway in Australia.
These projects illustrate the extraordinary quality and diversity of work being undertaken with NHMRC support.
Discrimination against an individual can appear in many forms. As DNA testing increasingly identifies differences in the genetic make-up of individuals, it becomes possible that people will be discriminated against based on genetic information.